scispace - formally typeset
H

Harminder D. Singh

Researcher at Torrey Pines Institute for Molecular Studies

Publications -  7
Citations -  454

Harminder D. Singh is an academic researcher from Torrey Pines Institute for Molecular Studies. The author has contributed to research in topics: Reductase & Multidrug tolerance. The author has an hindex of 6, co-authored 7 publications receiving 408 citations. Previous affiliations of Harminder D. Singh include University of Central Florida.

Papers
More filters
Journal ArticleDOI

Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice

TL;DR: This prophylactic protocol using a murine hemophilia B model was effective over a range of oral antigen doses, and controlled inhibitor formation and anaphylaxis long-term, up to 7 months (∼40% life span of this mouse strain).
Journal ArticleDOI

Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse.

TL;DR: Evidence is provided that Tat protein expression is sufficient to mediate cognitive abnormalities seen in HIV-infected individuals and the genetically engineered GT-tg mouse may be useful for improving the understanding of the neurological underpinnings of neuroAIDS-related behaviors.
Journal ArticleDOI

Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat

TL;DR: Among GT-tg mice, doxycycline significantly increased anxiety-like behavior in all tasks, commensurate with enhanced Western blot labeling of Tat1-86 protein in brain, displaying optimal effects with the 7-day regimen.
Journal ArticleDOI

Exposure to HIV-1 Tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice.

TL;DR: Exposure to HIV-1 Tat protein induced sensorimotor deficits associated with acute and persistent neuroinflammation in limbic/extralimbic brain regions and increased frontal cortex GFAP.
Journal ArticleDOI

Wax ester synthesis is required for Mycobacterium tuberculosis to enter in vitro dormancy.

TL;DR: The results indicate that the fcr1 and fcr2 gene products are involved in THE AUTHORS synthesis under in vitro dormancy-inducing conditions and that THEY play a critical role in reaching a dormant state in mycobacterial dormancy.